Borstkanker Onderzoek Groep
8 clinical trials · Sponsor
◉ Watch Borstkanker Onderzoek Groep
| Record | Firm | Date |
|---|---|---|
| SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast) (NCT05392608) | Borstkanker Onderzoek Groep | 2022-06-02 |
| TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer (NCT04489173) | Borstkanker Onderzoek Groep | 2020-09-25 |
| Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. (NCT03283384) | Borstkanker Onderzoek Groep | 2019-06-15 |
| Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study (NCT03820063) | Borstkanker Onderzoek Groep | 2019-02-27 |
| Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer (NCT03425838) | Borstkanker Onderzoek Groep | 2017-11-09 |
Track Borstkanker Onderzoek Groep automatically
Every clearance here is in the API, with alerts when new ones post.